Between the Belly and the Brain: Distorted Gut-brain Crosstalk in Early-life Adversity

NCT ID: NCT06922773

Last Updated: 2025-04-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-31

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to learn about the effects of early-life adversity (ELA) on the composition of children's microbiome and on their psychosocial functioning. The main questions it aims to answer are:

* Do children who have experienced ELA have lower gut microbial diversity and/or an altered gut microbial composition?
* Do these microbiome alterations correlate with adverse neurodevelopmental outcomes, including increased levels of stress, social and/or affective problems?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Early Life Adversity Microbiome, Human Anxiety Symptoms Depressive Symptoms Posttraumatic Stress Symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Completion of questionnaires; child psychiatric screening; faecal sample analysis

Completion of questionnaires:

* FFQ (Food Frequency Questionnaire) - completed by child
* KIDSCREEN-10 - completed by child
* CRIES-13 (Child Revised Impact of Events Scale) - completed by parents/guardian and child
* CTES (Childhood Trust Events Survey) - completed by parents/guardian
* RCADS-25 (Revised Children's Anxiety and Depression Scale) - completed by parents/guardian and child

Child psychiatric screening using SCID-5-Junior - semi-structured interview conducted with child and parent(s)/guardian

Faecal sample analysis:

* Beta-diversity (UniFrac and Bray-Curtis distance index)
* Firmicutes/Bacteroidetes ratio
* Abundance of Prevotella, Lactobacillaceae, Bifidobacteriacae and Lachnospiraceae
* Short-chain fatty acid metabolites

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary school-aged children (6 to 13 years of age) who have experienced at least one early-life traumatic event, based on the Childhood Trust Events Survey (CTES) questionnaire
* The child and at least one of his/her parents (or guardian) speak Dutch sufficiently well to complete all of the questionnaires and the semi-structured child psychiatric interview (SCID-5-Junior)

Exclusion Criteria

* any chronic disorders or diseases known to affect the gut micobiome
* inablity to complete questionnaires and/or semi-structured interview because of linguistic and/or cognitive barrier
* congenital or acquired immunodeficiencies
* use of medication(s) that affect gastrointestinal function (e.g., antibiotics) within the last 6 weeks, or laxatives within the last 4 weeks, or probiotic or prebiotic supplements within the last 4 weeks
* current involvement in another clinical or food study
Minimum Eligible Age

6 Years

Maximum Eligible Age

13 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitair Ziekenhuis Brussel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UZ Brussel

Jette, Brussels Capital, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sam L.B. Bonduelle, Master of Medicine

Role: CONTACT

+32 2 474 97 27

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23275_BELLYBRAIN

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Meaning-centered Intervention for Internalizing Symptoms
NCT07058181 ENROLLING_BY_INVITATION NA
Treating Suicidality Remotely
NCT06370104 RECRUITING NA